SUBSCRIBE
SUBSCRIBE

Phase III

Drug Development
Here Is What Vivek Ramaswamy Wrote To His Employees After Axovant’s Drug Failed
September 29, 2017
 · 
1 min read
Drug Development
A Frustrating Quest: Why Biogen Could Be Our Best Hope For Alzheimer’s Right Now
September 28, 2017
 · 
1 min read
Drug Development
Sinovac Biotech Ltd. Announces Early Positive Results For Chickenpox Vaccine
September 27, 2017
 · 
1 min read
Here’s the Best Career Advice from Axovant's CEO
Drug Development
Axovant’s Much-Hyped Alzheimer’s Drug Flunks Phase III Test
September 26, 2017
 · 
3 min read
Antares Pharma Implodes After FDA Responds to Its Xyosted NDA
Drug Development
Bay Area Versartis’s Stock Collapses as Growth Hormone Drug Flunks Phase III Test
September 22, 2017
 · 
2 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Drug Development
3 Biotechs With Make-or-Break Trial Results, FDA Meetings Coming Soon
September 22, 2017
 · 
3 min read
Alnylam Stock Craters After Deaths Cause Clinical Trial to End
Drug Development
Alnylam Stock Catapults as Genetic Disease Drug Meets All Phase III Goals
September 20, 2017
 · 
3 min read
Eli Lilly Dealt Another Setback as Lung Cancer Drug Flunks Phase III Test
Drug Development
Eli Lilly Heads to Finish Line with Breast Cancer Treatment Abemaciclib
September 19, 2017
 · 
3 min read
Why This Biotech, Up 300% Since May, Could be the Next Big M&A Target
Drug Development
Nabriva’s Stock Explodes as Pneumonia Drug Wows in Two Phase III Trials
September 18, 2017
 · 
2 min read
Massachusetts' Biostage Slashes 71% of Staff, Evaluating Strategic Alternatives
Drug Development
Bavarian Nordic Plummets 49% After Cancer Vaccine Flunks Late-Stage Test
September 15, 2017
 · 
2 min read
Load More
PRESS RELEASES
Press Releases
Idorsia to present long-term lucerastat data and kidney biopsy results at WORLDSymposium
January 30, 2026
 · 
9 min read
Press Releases
Quince Therapeutics Announces Topline Results from Pivotal Phase 3 NEAT Clinical Trial of eDSP in Ataxia-Telangiectasia
January 30, 2026
 · 
6 min read
Press Releases
Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.
January 29, 2026
 · 
7 min read
Press Releases
Ascletis Announces Positive Topline Results from Its Phase III Open-Label Study of Denifanstat (ASC40), a First-in-Class, Once-Daily Oral FASN Inhibitor for Acne
January 29, 2026
 · 
3 min read
Press Releases
Aicuris Announces Pritelivir Phase 3 HSV Data to Be Presented as Late-Breaking Oral Presentation at Tandem
January 29, 2026
 · 
2 min read
Press Releases
Tenpoint Therapeutics Ltd. Announces FDA Approval of YUVEZZI™, the First and Only Combination Eye Drop Approved to Treat Presbyopia
January 29, 2026
 · 
8 min read
Press Releases
First Patient Dosed in ACCEL: Phase 3 Chronic Idiopathic Constipation Study of IBSRELA
January 29, 2026
 · 
6 min read
Press Releases
Ensysce Biosciences Provides Enrollment Update on Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid for Severe Acute Pain
January 29, 2026
 · 
4 min read
Press Releases
OKYO Pharma Announces Successful Type C Meeting with the FDA
January 29, 2026
 · 
5 min read
Press Releases
Baseline Therapeutics Launches to Advance GLP-1RA Phase 3 Program in Alcohol Use Disorder
January 28, 2026
 · 
3 min read
Press Releases
Bayer to Present Results From Phase III OCEANIC-STROKE Study of Asundexian in Secondary Stroke Prevention
January 28, 2026
 · 
4 min read
Press Releases
Cloudbreak Pharma Announces Successful End-of-Phase-2 Meeting and Alignment with FDA on Phase 3 Path Forward for CBT-004
January 28, 2026
 · 
7 min read
Press Releases
Intellia Therapeutics Announces FDA Lift of Clinical Hold on MAGNITUDE-2 Phase 3 Clinical Trial in ATTRv-PN
January 28, 2026
 · 
6 min read
Press Releases
Sarepta Announces Positive Topline Three-Year EMBARK Results Showing ELEVIDYS Significantly Slows Disease Progression on Key Functional Measures in Ambulatory Duchenne Patients
January 27, 2026
 · 
16 min read
Press Releases
Scancell announces FDA clearance of IND application for global Phase 3 trial of iSCIB1+ in advanced melanoma
January 26, 2026
 · 
4 min read
Press Releases
Bausch Health Provides Update on RED-C Phase 3 Clinical Trials
January 26, 2026
 · 
3 min read
Press Releases
Vaxcyte Advances Adult and Infant Programs for VAX-31, a Potential Best-in-Class, Next-Generation Pneumococcal Conjugate Vaccine
January 23, 2026
 · 
17 min read
Press Releases
Overall Survival Primary Endpoint Met in Corcept’s Pivotal Phase 3 ROSELLA Trial of Relacorilant in Patients with Platinum-Resistant Ovarian Cancer
January 23, 2026
 · 
7 min read
Press Releases
New England Journal of Medicine Publishes Phase 3 ASCENT-04/KEYNOTE-D19 Results Supporting Trodelvy® Plus Keytruda® as a Potential New Standard of Care in First-line PD-L1+ Metastatic Triple-negative Breast Cancer
January 22, 2026
 · 
17 min read
Press Releases
IntraBio Announces Positive Pivotal Trial Results of Levacetylleucine for the Treatment of Ataxia-Telangiectasia
January 21, 2026
 · 
5 min read
Load More